5 things to know before the stock market opens

Stock futures rose this morning after US lawmakers passed a major procedural hurdle as part of an agreement that could end the nearly six-week shutdown; President Donald Trump has proposed issuing $2,000 “dividend” checks to Americans, which would be funded by tariff revenues; AI data center company CoreWeave (CRWV) is set to report its quarterly results after the closing bell today; Shares of Metsera (MTSR) fell after the weight-loss drug maker announced it would be acquired by Pfizer (PFE) after a bidding war with Novo Nordisk (NVO). Here’s what you need to know today.

1. Stock futures rise amid hopes for an end to the US government shutdown

Stock futures point to a higher open for major indexes after the Senate passed a key procedural vote as part of an agreement to end the more than month-long US government shutdown. Futures tied to the Dow Jones Industrial Average and the S&P 500 recently rose 0.4% and 0.9%, respectively, while contracts tied to the tech-heavy Nasdaq jumped 1.5%. Major market indexes lost ground last week amid slowing momentum behind AI trading and growing concerns about lockdowns. Bitcoin’s price reached nearly $106,000 in recent trading, up from a weekend low of about $101,500 and trading at a one-week high. Gold futures rose more than 2% to a two-week high above $4,100 an ounce. The yield on the 10-year Treasury note, which affects a range of consumer loans, was 4.13%, up from Friday’s close of 4.09%.

2. The Senate passes a key vote that could pave the way for reopening the government

The Senate on Sunday passed a procedural hurdle that could pave the way for the government to reopen after the longest shutdown in U.S. history. The Senate voted 60-40 on a measure that would allow others to vote on an agreement that could restore funding to government agencies that have been closed for more than 40 days. Eight Democrats joined Republicans in supporting the deal that would open the government until the end of January. While the agreement does not address the health care funding cuts that were at the heart of the shutdown, news reports said there would be a vote on support in December. One consequence of the lockdown has been a freeze in economic reports issued by government statistics agencies, which could affect reports this week on inflation and retail sales. Government officials also began restricting some air travel last week amid staffing issues for air traffic controllers.

3. Trump proposes paying a $2,000 tariff “dividend.”

President Donald Trump has proposed issuing a $2,000 stimulus payment to Americans, saying in a social media post that proceeds from tariffs could be used to fund the checks. “We are receiving trillions of dollars and will soon begin paying off our massive debt of $37 trillion,” Trump wrote in a post on the Truth Social website. “Dividends of at least $2,000 per person (not including high-income people!) will be distributed to everyone.” In office, Trump has defended his tariff policies, which are currently being challenged in a Supreme Court case challenging his authority to issue import taxes. Earlier this year, President Trump’s allies proposed a “DOGE dividend” from savings from spending cuts.

4. CoreWeave is expected to report a big jump in revenue

AI data center company CoreWeave (CRWV) is set to release its quarterly earnings report after markets close today, giving investors another look at AI trading amid recent volatility. CoreWeave recently announced a number of deals with major tech companies, including a $6.3 billion seed order with AI chip maker Nvidia and a $14.2 billion agreement with social media giant Meta. CoreWeave is expected to report that its revenue more than doubled from the same period last year to $1.3 billion, according to analysts surveyed by Visible Alpha. The company is expected to report an adjusted loss per share of $0.35. Shares of CoreWeave, which have risen 160% since the company’s initial public offering in March, rose nearly 5% in premarket trading.

5. Metsera shares decline after the pharmaceutical company announced its acquisition by Pfizer

Shares of Metsera (MTSR) fell after the weight-loss drug maker announced that Pfizer (PFE) has agreed to acquire the company. Metsera said it struck the deal with Pfizer after US regulators raised concerns that the offer from Danish pharmaceutical company Novo Nordisk (NVO) would create antitrust issues. The deal follows a bidding war between the two drugmakers for New York-based Metsera. Pfizer will pay $86.25 per share in the deal, which is said to be valued at more than $10 billion. Metsera shares fell 15% before the opening bell, while Pfizer shares rose.